Termination by AstraZeneca. (a) If Licensee fails to close the Financing and issue the License Shares to AstraZeneca during the Financing Period, AstraZeneca shall have the right to immediately terminate this Agreement in its entirety, including the rights of any Sublicensees, upon written notice to Licensee.
Appears in 2 contracts
Samples: License Agreement (Arcutis Biotherapeutics, Inc.), License Agreement (Arcutis Biotherapeutics, Inc.)
Termination by AstraZeneca. (ai) If In the event that the Licensee fails to does not close the Financing and issue by the License Shares to AstraZeneca during end of the Financing Period, then AstraZeneca shall have the right to immediately terminate this Agreement in its entirety, including the rights of any Sublicensees, upon written notice to Licenseewith immediate effect.
Appears in 2 contracts
Samples: Confidential Treatment (Biohaven Pharmaceutical Holding Co Ltd.), Confidential Treatment (Biohaven Pharmaceutical Holding Co Ltd.)
